The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
<h4>Background</h4>There is a high risk of Plasmodium vivax parasitaemia following treatment of falciparum malaria. Our study aimed to quantify this risk and the associated determinants using an individual patient data meta-analysis in order to identify populations in which a policy of u...
Similar Items
-
Insights into the early liver stage biology of Plasmodium
by: Lokesh D Kori, et al.
Published: (2018-01-01) -
α+Thalassemia Antagonizes the Malaria-protective Effects of Sickle-Cell Trait
by: Chanaki Amaratunga, et al.
Published: (2014-11-01) -
Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification
by: Pradeep Kumar Nagar, et al.
Published: (2020-01-01) -
Comparison of WHO Mark III and HRP II ELISA for in vitro sensitivity of Plasmodium falciparum
by: Supriya Sharma, et al.
Published: (2016-01-01) -
Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report
by: Deepali Savargaonkar, et al.
Published: (2017-01-01)